Lupin Limited Share Price and Company Fundamentals
Last traded: Today at 9:59 AM
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company also offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, women's health, and central nervous system areas, as well as pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies. In addition, it focuses on various therapeutic spectrum, including rheumatology, oncology, neuroscience, and renal therapies. Further, the company is involved in the provision of diagnostics services, and digital healthcare services; and neuro rehabilition business. It operates through network consists of labs and collection centers. The company has a strategic collaboration with TB Alliance for the development and commercialization of the investigational drug Telacebec for the treatment of multiple mycobacterial diseases including tuberculosis (TB), leprosy, and buruli ulcer. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
Key Metrics
PE ratio
21.91
PB ratio
5.17
Dividend yield
0.55%
Beta
0.30
Market cap
₹1015.15B
Enterprise value
₹1014.87B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 24006 |
| Website | https://www.lupin.com |
| Mailing address | Kalpataru Inspire 3rd Floor Off. Western Expressway Highway Santacruz (East) Mumbai 400055 India |
| Phone / Fax | 91 22 6640 2323 / 91 22 6640 2051 |
Dividends
Dividend yield
0.55%
Dividend amount
₹12.00
Payout ratio
11.83%
5Y Avg. yield
-%
Lupin Limited paid ₹12.00 dividend and the ex-dividend date was 25 Jul 2025.The dividend payout ratio is 11.83%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.LUPIN dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Lupin Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Ms. Vinita D. Gupta | CEO & Executive Director | 57 | |
| Mr. Ramesh Swaminathan | Executive Director, Global CFO, CRO & Head of API Plus SBU and IT | 59 | |
| Mr. Nilesh Deshbandhu Gupta | MD & Executive Director | 51 | |
| Mr. Christoph Funke | Chief Technical Operations Officer | ||
| Dr. Shahin Fesharaki | Chief Scientific Officer | ||
| Mr. Ravi Agrawal | Sr. Vice President of Investor Relations and M&A | ||
| Mr. Amit Kumar Gupta | Company Secretary & Compliance Officer | ||
| Ms. Rajalakshmi Azariah | Vice President & Global Head of Corporate Communications | ||
| Dr. Fabrice Egros M.B.A., Ph.D., Pharm.D. | President of Corporate Development | 62 | |
| Mr. Yashwant S. Mahadik B.Com, MBA | President of Global Human Resources | 58 |
Profitability and management effectiveness
Profit margin
17.76%
Operating margin
26.46%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Lupin Limited is 1015.15B and its enterprise value is 1014.87B. The enterprise value to revenue ratio of LUPIN is 3.88. The enterprise value to EBITDA ratio of LUPIN is 14.80.
The LUPIN's stocks Beta value is 0.30 making it 70% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Lupin Limited (NSE:LUPIN) Frequently Asked Questions
1. What is Lupin Limited's Stock Symbol?
Lupin Limited trades on NSE under the ticker symbol "LUPIN".
2. What is Lupin Limited's stock price today?
One share of LUPIN stock can currently be purchased for approximately ₹2221.5.
3. How can I contact Lupin Limited?
Lupin Limited's mailing address is Kalpataru Inspire 3rd Floor Off. Western Expressway Highway Santacruz (East) Mumbai 400055 India. The company can be reached via phone at 91 22 6640 2323.
4. What is Lupin Limited's official website?
The official website of Lupin Limited is https://www.lupin.com.